Dr Shah completed his medical studies at Imperial College London. He then trained in respiratory medicine in London including at Hammersmith, Chelsea & Westminster, Royal Brompton and Harefield hospitals.
He was awarded a Medical Research Council Clinical Research Training Fellowship in 2011 for research aiming to understand the susceptibility to fungal infection in solid organ transplantation. This research was performed at Imperial College London, and led to a PhD, multiple publications, international conferences and interest.
Dr Shah subsequently rejoined Royal Brompton and Harefield NHS Foundation Trust as a Consultant in 2016.
Areas of expertise
Dr Shah is a respiratory consultant with an expertise in infection and, in particular, fungal lung infection. These include patients with:
- Fungal lung infection (including aspergillosis)
- Host defense abnormalities
- Cystic fibrosis
- Primary ciliary dyskinesia
- Primary or secondary immunodeficiency
- Non-tuberculous mycobacteria.
Dr Shah has ongoing active research interests in a number of fields, but primarily focuses on how to better understand and improve the outcome in fungal lung disease. He has been awarded numerous research awards/grants as a Consultant and collaborates closely with academic colleagues at Imperial College London including Dr Darius Armstrong-James and Professor Matthew Fisher.
Current research interests include:
- Targeting Immunotherapy for Fungal Infections in Cystic Fibrosis (TrIFIC)
- Fungal Resistance Evolution and Acquisition in chronic Lung disease (FREAL)
- Evaluating tablet and web-based audiometry to detect and monitor hearing loss in cystic fibrosis
- Developing remote capillary blood testing to monitor chronic lung disease
- Use of deep learning to develop automated CT quantification in chronic pulmonary aspergillosis.
See a full description of Dr Anand Shah’s research activities and publications on his profile for Imperial.
See Dr Anand Shah's podcast here.
Dr Shah is a member of the British Thoracic Society Specialist Advisory Group for respiratory infection (2018 - current). He is also a member of the Antimicrobial Resistance in Cystic Fibrosis International Working Group.
Dr Shah collaborates with industry and has received numerous industry sponsored research innovation awards and investigator-led research grants. He is a sub-investigator on multiple multicenter international clinical trials.
Dr Shah supervises PhD and MSc students as well as medical students for research attachments. He has also sponsored two Darzi fellows in clinical leadership. He lectures about his clinical specialist areas and research at national and international meetings and is involved in public and patient education.
- MRC Clinical Academic Research Partnership award (2019)
- Cystic Fibrosis Mentored Research Innovation Award (2018)
- Gilead UK Fellowship in Invasive Fungal Infection (2017)
- Cystic Fibrosis Trust Clinical Excellence and Innovation Award (2017)
- NHS Darzi Fellowship in clinical leadership (2017 and 2018)
- MRC Clinical Research Fellowship (2011)
- London Deanery Postgraduate Education Fellowship (2010).